530 related articles for article (PubMed ID: 36926345)
21. CD8
Wang W; Green M; Choi JE; Gijón M; Kennedy PD; Johnson JK; Liao P; Lang X; Kryczek I; Sell A; Xia H; Zhou J; Li G; Li J; Li W; Wei S; Vatan L; Zhang H; Szeliga W; Gu W; Liu R; Lawrence TS; Lamb C; Tanno Y; Cieslik M; Stone E; Georgiou G; Chan TA; Chinnaiyan A; Zou W
Nature; 2019 May; 569(7755):270-274. PubMed ID: 31043744
[TBL] [Abstract][Full Text] [Related]
22. MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer.
Cheng B; Lai Y; Huang H; Peng S; Tang C; Chen J; Luo T; Wu J; He H; Wang Q; Huang H
Environ Toxicol; 2024 Feb; 39(2):927-941. PubMed ID: 37972062
[TBL] [Abstract][Full Text] [Related]
23. Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors.
Cai H; Ren Y; Chen S; Wang Y; Chu L
Front Oncol; 2023; 13():1119369. PubMed ID: 36845720
[TBL] [Abstract][Full Text] [Related]
24. Identification of ferroptosis-related signature with potential implications in prognosis and immunotherapy of renal cell carcinoma.
Liu L; Jin H; Dong M; Tian J; Li H; Liu Q; Chen Y; Zou Z
Apoptosis; 2022 Dec; 27(11-12):946-960. PubMed ID: 36028785
[TBL] [Abstract][Full Text] [Related]
25. Chemically Programmed Vaccines: Iron Catalysis in Nanoparticles Enhances Combination Immunotherapy and Immunotherapy-Promoted Tumor Ferroptosis.
Ruiz-de-Angulo A; Bilbao-Asensio M; Cronin J; Evans SJ; Clift MJD; Llop J; Feiner IVJ; Beadman R; Bascarán KZ; Mareque-Rivas JC
iScience; 2020 Sep; 23(9):101499. PubMed ID: 32919370
[TBL] [Abstract][Full Text] [Related]
26. Targeting ferroptosis for cancer therapy: iron metabolism and anticancer immunity.
Luo L; Wang H; Tian W; Zeng J; Huang Y; Luo H
Am J Cancer Res; 2021; 11(11):5508-5525. PubMed ID: 34873476
[TBL] [Abstract][Full Text] [Related]
27. Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer.
Ma L; Chen C; Zhao C; Li T; Ma L; Jiang J; Duan Z; Si Q; Chuang TH; Xiang R; Luo Y
Signal Transduct Target Ther; 2024 Mar; 9(1):64. PubMed ID: 38453925
[TBL] [Abstract][Full Text] [Related]
28. Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor Immunotherapy.
Lei H; Li Q; Pei Z; Liu L; Yang N; Cheng L
Small; 2023 Nov; 19(45):e2303438. PubMed ID: 37420331
[TBL] [Abstract][Full Text] [Related]
29. Targeting Cancer Cell Ferroptosis to Reverse Immune Checkpoint Inhibitor Therapy Resistance.
Deng J; Zhou M; Liao T; Kuang W; Xia H; Yin Z; Tan Q; Li Y; Song S; Zhou E; Jin Y
Front Cell Dev Biol; 2022; 10():818453. PubMed ID: 35399527
[TBL] [Abstract][Full Text] [Related]
30. Ferroptosis-mediated immune responses in cancer.
Qi D; Peng M
Front Immunol; 2023; 14():1188365. PubMed ID: 37325669
[TBL] [Abstract][Full Text] [Related]
31. Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology.
Yu Z; Mo Z; Qiu Y; Lu H; Zheng B; Liu L
Curr Pharm Biotechnol; 2024 Jan; ():. PubMed ID: 38284738
[TBL] [Abstract][Full Text] [Related]
32. Ferroptosis: a promising target for cancer immunotherapy.
Sun LL; Linghu DL; Hung MC
Am J Cancer Res; 2021; 11(12):5856-5863. PubMed ID: 35018229
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy.
Zheng Z; Su J; Bao X; Wang H; Bian C; Zhao Q; Jiang X
Front Immunol; 2023; 14():1247268. PubMed ID: 37600785
[TBL] [Abstract][Full Text] [Related]
34. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
[TBL] [Abstract][Full Text] [Related]
35. Emerging role of autophagy in anti-tumor immunity: Implications for the modulation of immunotherapy resistance.
Jiang T; Chen X; Ren X; Yang JM; Cheng Y
Drug Resist Updat; 2021 May; 56():100752. PubMed ID: 33765484
[TBL] [Abstract][Full Text] [Related]
36. Ferroptosis, radiotherapy, and combination therapeutic strategies.
Lei G; Mao C; Yan Y; Zhuang L; Gan B
Protein Cell; 2021 Nov; 12(11):836-857. PubMed ID: 33891303
[TBL] [Abstract][Full Text] [Related]
37. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
38. The association between ferroptosis-related patterns and tumor microenvironment in colorectal cancer.
He C; Gu X; Dong C; Xu Z; Liu L; Jiang B; Lu Y; Jiang X; Lu Z
Int Immunopharmacol; 2024 Jun; 134():112258. PubMed ID: 38744178
[TBL] [Abstract][Full Text] [Related]
39. The role of lipid metabolic reprogramming in tumor microenvironment.
Yang K; Wang X; Song C; He Z; Wang R; Xu Y; Jiang G; Wan Y; Mei J; Mao W
Theranostics; 2023; 13(6):1774-1808. PubMed ID: 37064872
[TBL] [Abstract][Full Text] [Related]
40. Ferroptosis, a subtle talk between immune system and cancer cells: To be or not to be?
Zhou Q; Tao C; Yuan J; Pan F; Wang R
Biomed Pharmacother; 2023 Sep; 165():115251. PubMed ID: 37523985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
